"Hemolysis, or not Hemolysis, that is the Question". Use of Hydroxychloroquine in a Patient with COVID-19 Infection and G6PD Deficiency

Mediterr J Hematol Infect Dis. 2020 Nov 1;12(1):e2020076. doi: 10.4084/MJHID.2020.076. eCollection 2020.

¹ Unit of Hematology and Stem Cell Transplantation, Azienda Ospedaliero-Universitaria Consorziale Policlinico, Bari, Italy.
² Anaesthesia and Intensive Care Unit II, General surgery, Gynecology and Anaesthesia Department, Azienda Ospedaliero-Universitaria Consorziale Policlinico, Bari, Italy.
³ University of Bari "Aldo Moro", Emergency and Organ Transplantation department, Bari, Italy.
⁴ Chair of Hematology and Unit of Hematology and Stem Cell Transplantation, "Aldo Moro" University School of Medicine, Azienda Ospedaliero-Universitaria Consorziale Policlinico, Bari, Italy.

No abstract available

Keywords: COVID-19; G6PD deficiency; Hydroxychloroquine; SARS-CoV-2.